SDSerge Dreuil

Serge Dreuil

*This is an algorithmically generated author record based on publicly available information.

Serge Dreuil has a total of 95 co-authors. Here are the top co-authors by number of shared publications:

  • Céline Bassinet

    Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), Fontenay-aux-Roses, France

    3 shared publications
  • Choonsik Lee

    National Cancer Institute, National Institutes of Health

    2 shared publications
  • Christelle Huet

    Institut de Radioprotection et de Sreté Nucléaire (IRSN), Service de Dosimétrie Externe, Laboratoire de Dosimétrie des Rayonnements Ionisants, Fontenay-aux-Roses, France

    2 shared publications
  • Cécile Etard

    Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, 31 Avenue de la Division Leclerc, 92260 Fontenay-aux- Roses, France

    2 shared publications
  • David Borrego

    Radiation Protection Division, US Environmental Protection Agency (EPA), Office of Radiation and Indoor Air, Washington DC, Washington, 20460, United States

    2 shared publications
  • Noëlle Pierrat

    French Society of Medical Physics (SFPM), Centre Antoine Béclère, 47 Rue de la Colonie, 75013 Paris, France; Medical Physics Department, Curie Institute, 26 Rue d'Ulm, 75005 Paris, France

    2 shared publications

Latest Publications

  • Open Access

    HARMONIC organ dose calculation framework for cardiac fluoroscopy

    by Jérémie Dabin, Mahmoud Abdelrahman, David Borrego, Haegin Han, Choonsik Lee, Richard W Harbron, Vadim Chumak, Angeliki Karambatsakidou, Serge Dreuil, I Thierry-Chef

    The HARMONIC study (health effects of cardiac fluoroscopy and modern radiotherapy in paediatrics) aims, among other objectives, to investigate the relationship between ionising radiation and cancer incidence in children treated by cardiac fluoroscopy procedures (HARMONIC-Cardio). This requires estimation of organ doses for a large patient cohort. A framework for accurate dose calculation was developed, and used to create a software tool for rapid dose estimates. Organ doses were calculated with MCNP6.2 Monte Carlo particle transport code. Eight realistic, anthropomorphic phantoms were used representing newborn, 1, 5, 10, 15 year old and adult patients. Only male phantoms were used for patients younger than 15; male and female for older patients). A large range of technical parameters was covered in the simulations, including 11 primary beam angles and seven secondary angles, four levels of beam filtration, three tube voltages and three field sizes. The absorbed dose was computed for 32 organs and tissues. The calculated organ doses were normalised to the air kerma-area product (PKA), a common modality-specific dose index, resulting in PKA-to-organ-dose conversion coefficients. These coefficients were extended by interpolation. Organ dose conversion coefficients were calculated for 22,176 exposure configurations and interpolated to a total of 2,667,600. The coefficients for 15 organs of interest for radiation protection and effective dose were embedded in HARMONIC-CardioDose: a software tool that enables users to estimate organ doses for virtually any exposure scenario within the simulation range. The program is in the form of a Python script or an executable file, and uses a simple Excel document for inputting technical parameters necessary for calculations. HARMONIC-CardioDose is a validated software tool for rapid estimate of organ doses for paediatric and adult patients undergoing interventional cardiology procedures. The tool is freely available to the medical and research community for supporting patient dosimetry

  • Management of pregnant or potentially pregnant patients undergoing diagnostic and interventional radiology procedures: Investigation of clinical routine practice

    by Dario Faj, Céline Bassinet, Hrvoje Brkić, Francesca De Monte, Serge Dreuil, Laura Dupont, Paolo Ferrari, Aoife Gallagher, Lara Gallo, Christelle Huet, et al.


  • Open Access

    Exposure to low-dose ionising radiation from cardiac catheterisation and risk of cancer: the COCCINELLE study cohort profile

    by Kossi Dovene Abalo, Sophie Malekzadeh-Milani, Sébastien Hascoët, Serge Dreuil, Tiphaine Feuillet, Sarah Cohen, Claire Dauphin, Sylvie Di Filippo, Stéphanie Douchin, François Godart, et al.

    Purpose The COCCINELLE study is a nationwide retrospective French cohort set up to evaluate the risk of cancer in patients who undergone cardiac catheterisation (CC) procedures for diagnosis or treatment of congenital heart disease during childhood. Participants Children who undergone CC procedures from 1 January 2000 to 31 December 2013, before the age of 16 in one of the 15 paediatric cardiology departments which perform paediatric CC in mainland France were included. The follow-up started at the date of the first recorded CC procedure until the exit date, that is, the date of death, the date of first cancer diagnosis, the date of the 18th birthday or the 31 December 2015, whichever occurred first. The cohort was linked to the National Childhood Cancer Registry to identify patients diagnosed with cancer and with the French National Directory for the Identification of Natural Persons to retrieve the patients’ vital status. Findings to date A total of 17 104 children were included in the cohort and followed for 110 335 person-years, with 22 227 CC procedures collected. Among the patients, 81.6% received only one procedure. Fifty-nine cancer cases were observed in the cohort. Standardised incidence ratios (SIRs) were increased for all-cancer (SIR=3.8, 95% CI: 2.9 to 4.9), leukaemia (SIR=3.3, 95% CI: 2.0 to 5.4), lymphoma (SIR=14.9, 95% CI: 9.9 to 22.5) and solid cancers excluding central nervous system (CNS) tumours (SIR=3.3, 95% CI: 2.0 to 5.5) compared with the general population. Future plans Dose reconstruction is currently underway to estimate individual cumulative doses absorbed to relevant organs, including red bone marrow and brain for respectively haematologic disorders and CNS tumours risk estimation. A dose–response analysis will be conducted with consideration to confounding factors such as age at exposure, gender, predisposing factors to cancer and other sources of medical diagnostic low-dose ionising radiation.


  • The HARMONIC project: Study design for assessment of cancer risks following cardiac fluoroscopy in childhood

    by Richard W Harbron, Isabelle Thierry-Chef, Mark S Pearce, Marie Odile Bernier, Serge Dreuil, Estelle Rage, Maria Grazia Andreassi, Eugenio Picano, Steffen Dreger, Hajo Zeeb, et al.

    The HARMONIC project (Health Effects of Cardiac Fluoroscopy and Modern Radiotherapy in Paediatrics) is a European study aiming to improve our understanding of the long-term health risks from radiation exposures in childhood and early adulthood. Here, we present the study design for the cardiac component of HARMONIC. A pooled cohort of approximately 100,000 patients who underwent cardiac fluoroscopy procedures in Belgium, France, Germany, Italy, Norway, Spain or the UK, while aged under 22 years, will be established from hospital records and/or insurance claims data. Doses to individual organs will be estimated from dose indicators recorded at the time of examination, using a lookup-table-based dosimetry system produced using Monte Carlo radiation transport simulations and anatomically realistic computational phantom models. Information on beam geometry and x-ray energy spectra will be obtained from a representative sample of radiation dose structured reports (RDSRs). Uncertainties in dose estimates will be modelled using 2-dimensional Monte Carlo methods. The cohort will be followed up using national registries and insurance records (Germany) to determine vital status and cancer incidence. Information on organ transplantation (a major risk factor for cancer development) and/or other conditions predisposing to cancer will be obtained from national or local registries and health insurance data, depending on country. The relationship between estimated radiation dose and cancer risk will be investigated using regression modelling. Results will improve information for patients and parents and aid clinicians in managing and implementing changes to reduce radiation risks without compromising medical benefits.


  • Patient dose evaluation in computed tomography: A French national study based on clinical indications

    by Bouchra Habib Geryes, Amaury Hornbeck, Valérie Jarrige, Noëlle Pierrat, Hubert Ducou Le Pointe, Serge Dreuil


  • SESAME: A TOOL FOR NUMERICAL DOSIMETRIC RECONSTRUCTION OF PATIENTS OVEREXPOSURES IN INTERVENTIONAL RADIOLOGY

    by Christelle Huet, Fabrice Entine, Céline Bassinet, Matthieu Dondey, Serge Dreuil, Jean-Louis Georges, Cécile Etard, Isabelle Clairand

    Radiation overexposure accidents are rare but can have severe health consequences. Evaluating the dose received by the patient is a crucial step in the medical management. For that purpose, for more than 15 years, IRSN has been developing an in-house tool named SESAME for the numerical reconstruction of radiological accidents due to external sources. Recently, two new functionalities were implemented in SESAME to allow accurate reconstructions of interventional radiology (IR) overexposures. The experimental validation of SESAME for the reconstruction of overexposures in IR is presented. First, an anthropomorphic dummy equipped with dosemeters was irradiated following conditions similar to a fluoroscopically guided interventional procedure. Then the procedure was simulated using SESAME. Finally measured doses were compared to calculated doses. Even with a limited amount of data available, SESAME can provide valuable dose information for the medical team in charge of the patient, such as skin dose mapping and dose distribution in depth.


  • Experimental evaluation of seven quality control phantoms for digital breast tomosynthesis

    by Julie Sage, Karen L. Fezzani, Isabelle Fitton, Lama Hadid, Aurélie Moussier, Noëlle Pierrat, Antoine Martineau, Serge Dreuil, Loïc Heulers, Cécile Etard


  • Exposure of the French population to ionizing radiations from medical diagnostic procedures in 2012

    by S. Dreuil, C. Etard

    Monitoring the exposure of the population to ionizing radiation is a European Union requirement. This article presents the exposure of the French population originating from medical diagnostic procedures performed in 2012. The number of procedures was established from a joint health insurances database. The effective dose associated with each procedure was estimated from various sources (national DRL, recent surveys, guides of procedures). The number of procedures was approximately 81.8 million, representing an average of 1247 examinations per 1000 inhabitants. The mean effective dose per inhabitant originating from medical diagnosis exposure was 1.6 mSv. When restricted to the population actually exposed, the average number of examinations was 2760 per 1000 individuals and the mean effective dose per exposed individual was 3.4 mSv. 70% of exposed individuals received less than 1 mSv. Mean individual exposure strongly increased with age: below 1 mSv before the age of 20, around 7 mSv at 75 years. 44% of the French population (49% of the women, 39% of the men) has benefited from at least one diagnosis procedure. Conventional radiology, dental radiology and computed tomography represented respectively 54%, 34% and 10.5% of the number of procedures and contributed to 18%, 0.2% and 71% of the collective effective dose, respectively. A 20% increase of the average effective dose per inhabitant was observed, when compared to the year 2007. While efforts are still needed in the optimization of delivered dose and in the harmonization of practices, whatever the imaging field, specific interest should be paid to the justification of certain examinations which have particularly increased in numbers.


  • Comparaison de la dose efficace en TEP/TDM et en TDM

    by J. Coulot, F. Magnier, P. Chauchat, N. Guilabert, M. Ricard, S. Dreuil, J. Lumbroso